Have a look at Polynovo.
Current market cap of about $1.4 B and five years ago the market cap was nothing.
Their main burns product had sales of $9m last year with total revenue of $13m.
Arguably, the market for Promoarker D is significantly higher than for burns treatments .
PIQ needs actual sales and if using Promarker D becomes accepted practice for identification
of kidney problems then we know the potential is extremely high.
As an example, identifying Malaria in Tanzania is done by a simple pin prick to the finger test and it is about 83%
accurate and it is the go to test used.
Clearly, Promarker D is for a different market but it remains to be seen if it becomes accepted practice .
Have a look at Polynovo. Current market cap of about $1.4 B and...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.005(0.46%) |
Mkt cap ! $143.3M | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.14 | $1.05 | $104.0K | 96.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 5000 | 1 |
View Market Depth
| Last trade - 15.22pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.10 |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| $1.08 | $1.11 | $1.05 | 24916 | ||
| Last updated 15.05pm 26/04/2024 ? | |||||
| PIQ (ASX) Chart |